Venture Advisor at Wellington Partners · Joined 2010
View Live Interactive Profile →Dr. Regina Hodits is a Venture Advisor at Wellington Partners, a role she took up in 2025 after serving as a Managing Partner of the firm. She holds a PhD in biochemistry and has worked in venture capital since 2000, previously as a Partner at Atlas Venture, an Investment Manager at Apax and a consultant at McKinsey & Company. She joined Wellington Partners in 2010 and oversaw more than 25 investments, 13 of them across the WPLS III to WPLS V funds. Her exits include Themis (acquired by MSD in 2020), Rigontec (MSD, 2017), Sapiens (Medtronic, 2014) and ONWARD Medical's Euronext IPO. She represented Wellington funds on the boards of Carisma, ONWARD, Sidekick, SNIPR Biome and STipe, served on the Advisory Council of KfW Capital, and was spokesperson for the board of the German private equity and venture capital association BVK from 2015 to 2020. In her advisor capacity she supports existing portfolio companies.